Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
468-01-011 ISMRM Abstract

Elevated Oxygen Extraction in Type 2 Diabetes: Early Cerebral Metabolic Changes in Cognition-Related Brain Regions

Primary: Neuro - Other Neurodegeneration
Secondary: Contrast Mechanisms - Susceptibility/QSM
468-01-011 · Quantitative Neuroimaging of Neurodegeneration, Metabolism, and Brain Microstructure · Tuesday, 12 May, 8:20 AM–9:15 AM · Digital Posters Row I
Keywords: Oxygen extraction fraction MRI Type 2 diabetes mellitus Quantitative Susceptibility Mapping (QSM) Brain metabolism
Accepted
Dhruv Bhagat1, Sri Sai L Akkineni1, Lea Bergeot2, Fahad Salman3, Ferdinand Schweser4, Junghun Cho5,6, Rafeeque Bhadelia7, Katherine L Tucker8, Salil Soman 9
1Medical College of Georgia, Augusta, United States of America
2Northeastern University, Boston, United States of America
3University of Buffalo, Buffalo, United States of America
4University at Buffalo, Buffalo, United States of America
5George Washington University, Washington, United States of America
6Biomedical Engineering, George Washington University, Washington, United States of America
7Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States of America
8University of Massachusetts Lowell, Lowell, United States of America
9UCSF-Radiology, United States of America
Presenting Author: Salil Soman

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1. Satapathy P, Pratima P, Gaidhane AM, et al. Prevalence and impact of microvascular complications in type 2 diabetes mellitus on cognitive impairment and depression: a systematic review and meta-analysis. Diabetol Metab Syndr 2025;17(1):187. (In eng). DOI: 10.1186/s13098-025-01759-9. [doi]
2. 2. Kumie G, Nigatie M, Alamrew A, et al. Prevalence of microvascular complications and associated factors among diabetes mellitus patients in Ethiopia: Systematic review and meta-analysis. Microvasc Res 2025;158:104779. (In eng). DOI: 10.1016/j.mvr.2024.104779. [doi]
3. 3. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man.
4. 4. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling.
5. 5. Korean Academy of Medical S. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults.
6. 6. Mahmood S, Dkhar W, Kadavigere R, et al. An analysis of brain structural changes in type 2 diabetes using advanced MRI techniques. Magn Reson Imaging 2025;121:110419. (In eng). DOI: 10.1016/j.mri.2025.110419. [doi]
7. 7. Fan Y, Tian J, Yu X, et al. Cortical Surface Spatial Analysis Reveals Altered Brain Functional Network Topology in T2DM With Mild Cognitive Impairment. Brain Behav 2025;15(4):e70489. (In eng). DOI: 10.1002/brb3.70489. [doi]
8. 8. Huang X, Diao Z, Shen D, et al. Macrostructural and microstructural alterations of hippocampal subregions in T2DM: NODDI provides added value to DTI and volumetric analyses. Brain Res Bull 2025;228:111417. (In eng). DOI: 10.1016/j.brainresbull.2025.111417. [doi]
9. 9. Sawada Y, Satoh T, Saba H, et al. Assessment of localized brain regions correlated with MMSE using VBM analysis of structural MRI in a Japanese sample. NeuroImage: Reports 2025;5(2):100264. DOI: https://doi.org/10.1016/j.ynirp.2025.100264. [doi]
10. 10. Li J, Zhang Q, Zhang N, Guo L. Increased Brain Iron Detection by Voxel-Based Quantitative Susceptibility Mapping in Type 2 Diabetes Mellitus Patients With an Executive Function Decline. Front Neurosci 2020;14:606182. (In eng). DOI: 10.3389/fnins.2020.606182. [doi]
11. 11. Hu R, Gao B, Tian S, et al. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus. Front Neurosci 2023;17:1061156. (In eng). DOI: 10.3389/fnins.2023.1061156. [doi]
12. 12. Pirozzi MA, Esposito F, Trojsi F, et al. In newly diagnosed diabetes, hyperglycemia is associated with increased brain iron deposition, measured by MRI-based Quantitative Susceptibility Mapping (QSM). J Adv Res 2025 (In eng). DOI: 10.1016/j.jare.2025.05.047. [doi]
13. 13. Mohammadi S, Ghaderi S, Sayehmiri F, Fathi M. Quantitative susceptibility mapping for iron monitoring of multiple subcortical nuclei in type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 2024;15:1331831. (In eng). DOI: 10.3389/fendo.2024.1331831. [doi]
14. 14. Hu B, Yu Y, Yu XW, et al. Sequence of episodic memory-related behavioral and brain-imaging abnormalities in type 2 diabetes. Nutr Diabetes 2025;15(1):1. (In eng). DOI: 10.1038/s41387-025-00359-w. [doi]
15. 15. Wang N, Chen X. Diagnostic value of Montreal cognitive assessment combined with olfactory tests for mild cognitive impairment in older adult patients with type 2 diabetes. Eur Geriatr Med 2025 (In eng). DOI: 10.1007/s41999-025-01223-x. [doi]
16. 16. Zhao Q, Maimaitiaili S, Bi Y, et al. Brain Iron Deposition Alterations in Type 2 Diabetes Mellitus Patients With Mild Cognitive Impairment Based on Quantitative Susceptibility Mapping. J Diabetes 2025;17(1):e70052. (In eng). DOI: 10.1111/1753-0407.70052. [doi]
17. 17. Sui C, Li M, Zhang Q, et al. Increased brain iron deposition in the basial ganglia is associated with cognitive and motor dysfunction in type 2 diabetes mellitus. Brain Res 2025;1846:149263. (In eng). DOI: 10.1016/j.brainres.2024.149263. [doi]
18. 18. Ni MH, Li ZY, Sun Q, et al. Neurovascular decoupling measured with quantitative susceptibility mapping is associated with cognitive decline in patients with type 2 diabetes. Cereb Cortex 2023;33(9):5336–5346. (In eng). DOI: 10.1093/cercor/bhac422. [doi]
19. 19. Ramos-Cazorla P, Carazo-Barrios L, Reyes-Bueno JA. Olfactory Dysfunction as a Biomarker for Early Diagnosis of Cognitive Impairment in Patients With Type 2 Diabetes: A Systematic Review. J Diabetes Res 2024;2024:9933957. DOI: 10.1155/jdr/9933957. [doi]
20. 20. Zhang S, Zhang Y, Wen Z. Cognitive dysfunction in diabetes: abnormal glucose metabolic regulation in the brain. Front Endocrinol (Lausanne) 2023;14:1192602. DOI: 10.3389/fendo.2023.1192602. [doi]
21. 21. Sun Y, Ma C, Sun H. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease. J Diabetes Res 2020;2020:4981814. DOI: 10.1155/2020/4981814. [doi]
22. 22. Bai L, Zhou Y, Zhang J, Ma J. The Role of a Ketogenic Diet in the Treatment of Dementia in Type 2 Diabetes Mellitus. Nutrients 2023;15(8):1971. DOI: 10.3390/nu15081971. [doi]
23. 23. Cai YH, Wang Z, Feng LY, Ni GX. Effect of Exercise on the Cognitive Function of Older Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Front Hum Neurosci 2022;16:876935. DOI: 10.3389/fnhum.2022.876935. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/468-01-011